# Efficacy and Safety of G-CSF in Patients With Severe Alcoholic Hepatitis With Null or Partial Response to Steroid

> **NCT02442180** · PHASE3 · TERMINATED · sponsor: **Chuncheon Sacred Heart Hospital** · enrollment: 64 (actual)

## Conditions studied

- Alcoholic Hepatitis

## Interventions

- **DRUG:** G-CSF (Filgrastim injection)
- **DRUG:** steroid
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02442180
- **Lead sponsor:** Chuncheon Sacred Heart Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-07
- **Primary completion:** 2022-07
- **Final completion:** 2022-07
- **Target enrollment:** 64 (ACTUAL)
- **Why stopped:** failure to recruit eligible patients
- **Last updated:** 2022-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02442180

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02442180, "Efficacy and Safety of G-CSF in Patients With Severe Alcoholic Hepatitis With Null or Partial Response to Steroid". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02442180. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*